Table 3. Prevalence of Congenital Cardiovascular Malformations (CCM) and Lesion Status at One Year of Age Among the Neonatal Cohort.
| CCM | HIV-Infected (n = 90) | Follow-up HIV-Infected (n = 85) | HIV-Uninfected (n = 449) | Follow-up HIV-Uninfected (n = 412) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|||||||
| No. Infants | % | Persisted | Resolved | Unknown | No. Infants | % | Persisted | Resolved | Unknown | |
| Cyanotic lesion | 1 | 1.1 | 1 | 1 | 0.2 | 1 | ||||
| Secundum atrial septal defect | 2 | 2.2 | 1 | 1 | 5 | 1.1 | 3 | 2 | ||
| Ventricular septal defect | 3 | 3.3 | 2 | 1 | 8 | 1.8 | 1 | 6 | 1 | |
| Patent ductus arteriosus* | 1 | 1.1 | 1 | 5 | 1.1 | 3 | 1 | 1 | ||
| Supravalvar pulmonary stenosis | 1 | 1.1 | 1 | 0 | ||||||
| Bicuspid aortic valve | 0 | 2 | 0.5 | 2 | ||||||
| Persistent left superior vena cava | 0 | 1 | 0.2 | 1 | ||||||
| Coronary arteriovenous fistula | 0 | 3 | 0.7 | 2 | 1 | |||||
| No. infants and percent | 8 | 8.9 | 6/85 | 2/85 | 0/85 | 25 | 5.6 | 13/412 | 10/412 | 2/412 |
| 7.1% | 2.4% | 0.0% | 3.2% | 2.4% | 0.5% | |||||
*
Each of the three HIV indeterminate infants with a CCM had a patent ductus arteriosus.